Nationwide survey of acromegaly in South Korea

Clinical Endocrinology

Volumn 78, Issue 4, 2013, Pages 577-585

  Kwon, Obin ^a   Song, Young Duk ^b   Kim, Seong Yeon ^c   Lee, Eun Jig ^a  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C;

ACROMEGALY; ADENOIDECTOMY; ADENOMA; ADULT; AGED; CHILD; FEMALE; GROWTH HORMONE BLOOD LEVEL; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SOUTH KOREA; TERTIARY HEALTH CARE; TRANSSPHENOIDAL SURGERY; TUMOR VOLUME;

EID: 84871995095     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12020     Document Type: Article

References (34)

1. Duncan, E., &, Wass, J.A., (1999) Investigation protocol: acromegaly and its investigation. Clinical Endocrinology, 50, 285-293.
2. Melmed, S., Colao, A., Barkan, A., et al,. (2009) Guidelines for acromegaly management: an update. Journal of Clinical Endocrinology and Metabolism, 94, 1509-1517.
3. Holdaway, I.M., &, Rajasoorya, C., (1999) Epidemiology of acromegaly. Pituitary, 2, 29-41.
4. Mestron, A., Webb, S.M., Astorga, R., et al,. (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). European Journal of Endocrinology, 151, 439-446.
5. T'Sjoen, G., Bex, M., Maiter, D., et al,. (2007) Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly. European Journal of Endocrinology, 157, 411-417.
6. Petersenn, S., Buchfelder, M., Reincke, M., et al,. (2008) Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register. European Journal of Endocrinology, 159, 525-532.
7. Kauppinen-Makelin, R., Sane, T., Reunanen, A., et al,. (2005) A nationwide survey of mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism, 90, 4081-4086.
8. Lee, S.J., Chough, C.B., Kim, C.H., et al,. (1965) Two cases of active acromegaly. Korean Journal of Internal Medicine, 8, 241-246.
9. Woo, M.S., Kim, E.Z., Huh, K.B., et al,. (1975) A clinical study on acromegaly and giantism. Korean Journal of Internal Medicine, 18, 1091-1096.
10. Kim, H.J., Lee, Y.Y., Yim, C.H., et al,. (1998) Outcome of surgery and radiotherapy in acromegaly. Journal of Korean Society of Endocrinology, 13, 156-166.
11. Yang, I., (1994) Clinical characteristics of acromegalic patients in Korea. Journal of Korean Society of Endocrinology, 9, 290-306.
12. Petersenn, S., Buchfelder, M., Gerbert, B., et al,. (2009) Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register. Clinical Endocrinology, 71, 400-405.
13. Reincke, M., Petersenn, S., Buchfelder, M., et al,. (2006) The German Acromegaly Registry: description of the database and initial results. Experimental and Clinical Endocrinology & Diabetes, 114, 498-505.
14. Kim, Y., &, Yang, B., (2009) The trend in catastrophic health payments by income strata in South Korea. The Korean Journal of Health Economics and Policy, 15, 59-77.
15. Kim, M.H., Kim, S.H., Chang, J.C., et al,. (1990) Changing pattern of patients in the tertiary care hospitals after National Medical Insurance implementation. Journal of Korean Society for Health Education and Promotion, 7, 27-32.
16. Tanaka, S., Fukuda, I., Hizuka, N., et al,. (2010) Gender differences in serum GH and IGF-I levels and the GH response to dynamic tests in patients with acromegaly. Endocrine Journal, 57, 477-483.
17. Alexopoulou, O., Bex, M., Abs, R., et al,. (2008) Divergence between growth hormone and insulin-like growth factor-1 concentrations in the follow-up of acromegaly. Journal of Clinical Endocrinology and Metabolism, 93, 1324-1330.
18. Clemmons, D.R., Van Wyk, J.J., Ridgway, E.C., et al,. (1979) Evaluation of acromegaly by radioimmunoassay of somatomedin-C. New England Journal of Medicine, 301, 1138-1142.
19. Puder, J.J., Nilavar, S., Post, K.D., et al,. (2005) Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 90, 1972-1978.
20. Pokrajac, A., Wark, G., Ellis, A.R., et al,. (2007) Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice. Clinical Endocrinology, 67, 65-70.
21. Feek, C.M., McLelland, J., Seth, J., et al,. (1984) How effective is external pituitary irradiation for growth hormone-secreting pituitary tumors? Clinical Endocrinology, 20, 401-408.
22. Chanson, P., Salenave, S., Kamenicky, P., et al,. (2009) Pituitary tumours: acromegaly. Best Practice and Research. Clinical Endocrinology and Metabolism, 23, 555-574.
23. Giustina, A., Barkan, A., Casanueva, F.F., et al,. (2000) Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 85, 526-529.
24. Bex, M., Abs, R., T'Sjoen, G., et al,. (2007) AcroBel-the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects. European Journal of Endocrinology, 157, 399-409.
25. Giustina, A., Chanson, P., Bronstein, M.D., et al,. (2010) A consensus on criteria for cure of acromegaly. Journal of Clinical Endocrinology and Metabolism, 95, 3141-3148.
26. Kim, E.H., Oh, M.C., Lee, E.J., et al,. (2012) Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly. Neurosurgery, 70, 1106-1113.
27. Feelders, R.A., Bidlingmaier, M., Strasburger, C.J., et al,. (2005) Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels. Journal of Clinical Endocrinology and Metabolism, 90, 6480-6489.
28. Weissberger, A.J., Ho, K.K., &, Lazarus, L., (1991) Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 72, 374-381.
29. Freda, P.U., (2009) Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clinical Endocrinology, 71, 166-170.
30. Kaltsas, G.A., Isidori, A.M., Florakis, D., et al,. (2001) Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. Journal of Clinical Endocrinology and Metabolism, 86, 1645-1652.
31. Clayton, R.N., Stewart, P.M., Shalet, S.M., et al,. (1999) Pituitary surgery for acromegaly. Should be done by specialists. BMJ, 319, 588-589.
32. Lissett, C.A., Peacey, S.R., Laing, I., et al,. (1998) The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Clinical Endocrinology, 49, 653-657.
33. Yang, I.M., Kim, J.W., Kim, Y.S., et al,. (1988) Long-term treatment of acromegaly with somatostatin analogue SMS 201-995. Journal of Korean Society of Endocrinology, 3, 175-181.
34. Dekkers, O.M., Biermasz, N.R., Pereira, A.M., et al,. (2008) Mortality in acromegaly: a metaanalysis. Journal of Clinical Endocrinology and Metabolism, 93, 61-67.